Loading…
MIRA Pharmaceuticals, Inc. is projected to rise to $1.17 by 2027, a +26% move from its current price of $0.9245. MIRA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.8966 | $0.9246 | $0.9536 | +0.01% |
| Jul 14 | $0.8853 | $0.9248 | $0.9659 | +0.03% |
| Jul 15 | $0.8768 | $0.9249 | $0.9756 | +0.04% |
| Jul 16 | $0.8697 | $0.925 | $0.9838 | +0.06% |
| Jul 17 | $0.8635 | $0.9251 | $0.9911 | +0.07% |
| Jul 18 | $0.858 | $0.9253 | $0.9978 | +0.08% |
| Jul 19 | $0.8529 | $0.9254 | $1.00 | +0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8529 | $0.9254 | $1.00 | +0.10% |
| Week 2 | $0.8254 | $0.9263 | $1.04 | +0.19% |
| Week 3 | $0.8051 | $0.9272 | $1.07 | +0.29% |
| Week 4 | $0.7885 | $0.9281 | $1.09 | +0.39% |
| Week 5 | $0.7742 | $0.929 | $1.11 | +0.49% |
| Week 6 | $0.7616 | $0.9299 | $1.14 | +0.58% |
| Week 7 | $0.7502 | $0.9308 | $1.15 | +0.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial.
It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc.
was incorporated in 2020 and is based in Miami, Florida.
MIRA Pharmaceuticals, Inc. (MIRA) is trading at $0.902. Its market capitalization is $37.9M and it ranks 4675. The price outlook is bullish over the long term, with the average forecast rising to $1.23 by 2030, to $2.29 by 2040, and to $3.62 by 2050, with a max forecast up to $7.16 by 2050.
A major floor 14.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.4% away) — a key level to hold.
The nearest ceiling, 16.8% above — a clean break opens room to run.
A major ceiling 34.1% above — clearing it would confirm fresh momentum.
Key MIRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MIRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.93 | Sell | $0.9278 | Sell |
| MA 10 | $0.9449 | Sell | $0.936 | Sell |
| MA 20 | $0.9443 | Sell | $0.9497 | Sell |
| MA 50 | $0.9842 | Sell | $0.9887 | Sell |
| MA 100 | $1.05 | Sell | $1.06 | Sell |
| MA 200 | $1.24 | Sell | $1.16 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.22 | Neutral |
| Stoch RSI (14) | 38.98 | Neutral |
| CCI (20) | -74.29 | Neutral |
| Williams %R (14) | -78.70 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -3.04 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 21.30 | Neutral |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 39.99 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 0.91 | Buy |
| ADX (14) | 11.92 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is bearish. RSI14 is 40, indicating modest negative momentum. The stock is trading near the support level of $0.902 while facing resistance at $1.15. The moving averages show SMA50 at $0.9879 and SMA200 at $1.24, underscoring a fragile near-term setup.
The 30-day range spans from $0.7284 to $1.12, and the stock carries substantial volatility (annualized volatility around 60%).
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.902 | $0.9245 | $1.25 | 0% | Neutral | |
| $0.9177 | $1.17 | $1.58 | +26% | Bullish | |
| $0.9273 | $1.22 | $1.71 | +32% | Bullish | |
| $0.8688 | $1.17 | $1.70 | +27% | Bullish | |
| $0.9213 | $1.27 | $1.90 | +38% | Bullish | |
| $0.8605 | $1.21 | $1.85 | +31% | Bullish | |
| $0.885 | $1.27 | $1.99 | +38% | Bullish | |
| $1.14 | $1.67 | $2.65 | +80% | Bullish | |
| $1.19 | $1.78 | $2.88 | +92% | Bullish | |
| $1.18 | $1.79 | $2.93 | +93% | Bullish | |
| $1.49 | $2.45 | $4.30 | +165% | Bullish | |
| $2.07 | $3.90 | $7.55 | +322% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.902 | $0.9245 | $1.12 | +0.00% |
| August 2026 | $0.7792 | $0.923 | $1.13 | -0.16% |
| September 2026 | $0.7841 | $0.9363 | $1.16 | +1.43% |
| October 2026 | $0.8242 | $0.9908 | $1.24 | +5.82% |
| November 2026 | $0.8309 | $1.00 | $1.26 | +1.40% |
| December 2026 | $0.812 | $0.9871 | $1.25 | -1.75% |
Click any year to see its month-by-month MIRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The MIRA price prediction for 2026 points to an average of $0.9245 (low $0.902, high $1.25) — a potential gain of 0% on today's $0.9245. Price action looks broadly range-bound.
In 2027, MIRA is projected to trade between $0.9177 and $1.58, averaging $1.17 — a potential gain of +26% from today's $0.9245. That is up +26% on the projected 2026 average. Buyers look set to stay in control over this stretch.
MIRA Pharmaceuticals, Inc.'s 2028 outlook centres on $1.22, within a $0.9273 to $1.71 range. That is up +4% on the projected 2027 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2029, MIRA could reach as high as $1.70, with a base case around $1.17 and support toward $0.8688 — roughly +27% from $0.9245. Buyers look set to stay in control over this stretch.
Expect MIRA to range from $0.9213 to $1.90 through 2030. The $1.27 average target implies a +38% move from current prices. That is up +9% on the projected 2029 average. Momentum favours further upside here.
The MIRA price prediction for 2031 points to an average of $1.21 (low $0.8605, high $1.85) — a potential gain of +31% on today's $0.9245. Buyers look set to stay in control over this stretch.
In 2032, MIRA is projected to trade between $0.885 and $1.99, averaging $1.27 — a potential gain of +38% from today's $0.9245. That is up +5% on the projected 2031 average. Momentum favours further upside here.
MIRA Pharmaceuticals, Inc.'s 2033 outlook centres on $1.67, within a $1.14 to $2.65 range. That is up +31% on the projected 2032 average. That marks a +80% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, MIRA could reach as high as $2.88, with a base case around $1.78 and support toward $1.19 — roughly +92% from $0.9245. Momentum favours further upside here.
Expect MIRA to range from $1.18 to $2.93 through 2035. The $1.79 average target implies a +93% move from current prices. That is up 0% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The MIRA price prediction for 2040 points to an average of $2.45 (low $1.49, high $4.30) — a potential gain of +165% on today's $0.9245. Momentum favours further upside here.
In 2050, MIRA is projected to trade between $2.07 and $7.55, averaging $3.90 — a potential gain of +322% from today's $0.9245. That is up +59% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in MIRA today (≈ 1,081.665765 MIRA) could be worth
$4,215.63
+$3,215.63 (+322%) by 2050 · US Dollar
Based on the average projected MIRA price of $3.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MIRAwould be worth at today's price.
$1,000 invested in MIRA on Jul 10, 2025 (≈ 833.3333 MIRA) would be worth
$770.42
-$229.58 (-23.0%) today · 0.77× · US Dollar
Based on a MIRA entry price of $1.2 vs. today's $0.9245.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.945 | $978.31 | -2.2% |
| 1 month ago | $0.98 | $943.37 | -5.7% |
| 3 months ago | $0.997 | $927.28 | -7.3% |
| 6 months ago | $1.48 | $624.66 | -37.5% |
| 1 year ago | $1.2 | $770.42 | -23.0% |
| All time (2.9y) ago | $7.42 | $124.6 | -87.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MIRA forecast.
Our base-case forecast reaches $1.80 around 2040.
Implied market cap at $1.80: $75.64M
The multi-year forecast shows a generally bullish trajectory from 2027 onward, with steady upside in average price and notable increases in later years. In 2027, the avg price is forecast at $1.14 (min $0.8952, max $1.56) with ROI of 26.9 and bullish sentiment. In 2028, the avg price is $1.19 (min $0.8983, max $1.69) with ROI 31.7 and bullish sentiment, followed by 2029 at avg $1.13 (min $0.833, max $1.66) with ROI 25.6.
By 2030, the avg price is forecast at $1.23 (min $0.8806, max $1.85) with ROI 36.2 and bullish sentiment, and 2031 at avg $1.15 (min $0.8088, max $1.79) with ROI 28. 2032 shows avg $1.20 (min $0.8233, max $1.90) with ROI 33.1 and bullish sentiment, while 2033 widens to avg $1.59 (min $1.07, max $2.56) with ROI 76.3 and bullish sentiment, and 2034 to avg $1.69 (min $1.12, max $2.78) with ROI 87.7. 2035 carries avg $1.69 (min $1.10, max $2.83) with ROI 87.9 and bullish sentiment.
The forecast strongens further into 2040 with avg $2.29 (min $1.36, max $4.09) and ROI 153.8, maintaining bullish sentiment. By 2050, the avg price is forecast at $3.62 (min $1.86, max $7.16) with ROI 301.5 and bullish sentiment. Overall, the profile points to meaningful upside across the coming years, albeit with the inherent uncertainty and volatility typical of a pre-clinical-stage pharmaceutical equity.
Tap a question to reveal the answer.
Avg $1.23; min $0.8806; max $1.85; ROI 36.2; sentiment BULLISH.
Forecasts show bullish sentiment in 2027 and beyond, with avg prices rising to $1.14 in 2027, $1.19 in 2028, and $3.62 by 2050, with ROIs up to 301.5.
Yes—the max forecast reaches $4.09 in 2040 and $7.16 in 2050.
Current price $0.902; Market cap $37.9M; Rank 4675.
30-day range low $0.7284; high $1.12.
MIRA Pharmaceuticals, Inc. Community Discussion
0Share your MIRA Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.